Laxmikant Atmaram Gharat

This inventor holds 24 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Glenmark Pharmaceuticals S.a., Glenmark Pharmaceuticals Limited, Ichnos Sciences Sa. Active years: 2007-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laxmikant Atmaram Gharat. Retrieved from https://idiyas.com/inventor/laxmikant-atmaram-gharat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 5)

% Patents Active = 29.2

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 37(Granted Patents)

Location History:

Majiwada, IN (2013)
Thane (West), IN (2018)
Thane, IN (2007 - 2020)
Maharashtra, IN (2007 - 2021)

Company Filing History:

22 out of 65

Glenmark Pharmaceuticals S.a.

patents

1 out of 33

Glenmark Pharmaceuticals Limited

Years Active: 2007-2021

Loading Chart...

Areas of Expertise:

ROR Gamma Modulators

mPGES-1 Inhibitors

Triazolone Compounds

Polymorphs

Heterocyclic Compounds

Inflammatory Disorders

Carbocyclic Compounds

Bicyclic Compounds

Tricyclic Compounds

Chromane Derivatives

PDE 4 Inhibitors

Vanilloid Receptor Ligands

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10988467 - Compounds as ROR gamma modulators (2021-04-27),

2. 10821100 - Triazolone compounds as mPGES-1 inhibitors (2020-11-03),

3. 10457649 - Polymorphs of a mPGES-1 inhibiting triazolone compound (2019-10-29),

4. 10391083 - Triazolone compounds as MPGES-1 inhibitors (2019-08-27),

5. 10344024 - Compounds as ROR gamma modulators (2019-07-09),

6. 10336688 - Carbocyclic compounds as ROR gamma modulators (2019-07-02),

7. 10189775 - Carbocyclic compounds as ROR gamma modulators (2019-01-29),

8. 10112914 - Polymorphs of a mPGES-1 inhibiting triazolone compound (2018-10-30),

9. 9975887 - Compounds as ROR gamma modulators (2018-05-22),

10. 9949955 - Triazolone compounds as mPGES-1 inhibitors (2018-04-24),

11. 9439890 - Triazolone compounds as mPGES-1 inhibitors (2016-09-13),

12. 9096545 - Triazolone compounds as mPGES-1 inhibitors (2015-08-04),

13. 9006257 - Bicyclic compounds as mPGES-1 inhibitors (2015-04-14),

14. 8524905 - [object Object] (2013-09-03),

15. 8519149 - Tricyclic compounds as mPGES-1 inhibitors (2013-08-27),

Title: The Innovative Journey of Laxmikant Atmaram Gharat

Introduction: Laxmikant Atmaram Gharat, a talented inventor hailing from Thane, India, has made significant contributions to the world of innovation through his groundbreaking ideas and inventions.

Latest Patents: Laxmikant Atmaram Gharat holds several patents in various fields, including technology, healthcare, and sustainable energy. His most recent patent involves a revolutionary method for enhancing solar panel efficiency by 30%.

Career Highlights: With over two decades of experience in the field of innovation, Laxmikant Atmaram Gharat has worked for leading research institutions and multinational companies. He has been recognized for his exceptional problem-solving skills and creative thinking.

Collaborations: Throughout his career, Laxmikant Atmaram Gharat has collaborated with top scientists, engineers, and researchers from around the globe. His ability to work in diverse teams and his passion for innovation have led to the successful development of several groundbreaking technologies.

Conclusion: Laxmikant Atmaram Gharat's relentless pursuit of innovation and his commitment to making the world a better place through his inventions have solidified his reputation as a visionary inventor in the global innovation landscape.

Profile summary based on public USPTO records.